Institution
Ivano-Frankivsk National Medical University
Recent research
- BiologyOpen access
Daraxonrasib (RMC-6236), the first orally bioavailable pan-RAS(ON) inhibitor, produced a significant survival benefit in the Phase 3 RASolute 302 trial in previously treated metastatic pancreatic ductal adenocarcinoma (PDAC), reducing the risk of death by 60% versus chemotherapy...
- Health & MedicineOpen access
Background/Aims: Gastrointestinal (GI) cancers accounted for 3.24 million deaths worldwide in 2022. Endoscopic submucosal dissection (ESD) enables en bloc resection of early neoplasms but is time-intensive and technically challenging. Hybrid ESD (H-ESD), which combines dissection...
- BiologyOpen access
Mountain hay meadows are among the most species-rich grassland habitats in Europe, yet many have been historically ploughed and later re-established under traditional management. We examined the legacy effects of past ploughing on plant diversity, vegetation composition, and soil...
- Health & MedicineOpen access
A pioneering faculty training program for artificial intelligence in Ukrainian medical education
The global higher education landscape is undergoing a profound transition due to the convergence of digital technologies and pedagogical theory. In medical education, large language models now demonstrate clinical reasoning capabilities comparable to those of medical students, ye...
- BiologyOpen access
BACKGROUND: Drugs that inhibit phosphodiesterase 10A (PDE10A) activity have shown efficacy in animal models. However, clinical trials of PDE10A inhibitors in patients with schizophrenia have failed to provide clinically significant results up to this point. Our study investigated...